European Case Law Identifier: | ECLI:EP:BA:2002:J000801.20020606 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 06 June 2002 | ||||||||
Case number: | J 0008/01 | ||||||||
Application number: | 98967133.4 | ||||||||
IPC class: | A61K 7/48 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | A | ||||||||
Download and more information: |
|
||||||||
Title of application: | Serine protease and topical retinoid compositions | ||||||||
Applicant name: | Johnson & Johnson Consumer Companies, Inc. | ||||||||
Opponent name: | - | ||||||||
Board: | 3.1.01 | ||||||||
Headnote: | 1. The jurisdiction of a (purported) designated Office according to Article 26 PCT covers the issue of whether an omitted designation can be validly added or not. 2. Publication of a correction concerning designations should address the same public as the publication of the wrong data to safeguard the interest of the public. |
||||||||
Relevant legal provisions: | |||||||||
Keywords: | International patent application - correction under Rule 88 EPC Jurisdiction of the EPO as a (purported) designated office to decide on a request for correction Balancing rights of third parties with those of the applicant |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/j010008ex1.html
Date retrieved: 17 May 2021
16 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.PCT Articles
PCT Implementing Rules
Offical Journal of the EPO
XOJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)
XOJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)
XOJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)